ECOR
electroCore, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.21
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 37.0M | 32.0M | 25.2M | 16.0M | 8.6M |
| Cost of Revenue | 4.8M | 4.2M | 3.8M | 2.8M | 1.6M |
| Gross Profit | 32.2M | 27.8M | 21.4M | 13.2M | 7.0M |
| Operating Expenses | |||||
| R&D Expense | 3.1M | 2.7M | 2.4M | 5.3M | 5.5M |
| SG&A Expense | 43.0M | 38.2M | 31.2M | 26.7M | 24.3M |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 46.1M | 40.9M | 33.6M | 32.0M | 29.9M |
| Cost and Expenses | 50.9M | 45.2M | 37.3M | 34.8M | 31.5M |
| Operating Income (EBIT) | (13.9M) | (13.2M) | (12.2M) | (18.8M) | (22.9M) |
| Non-Operating | |||||
| Interest Income | 199.0K | 298.0K | 572.0K | 433.0K | 287.0K |
| Interest Expense | 1.2M | 590.0K | — | — | — |
| Net Interest Income | (972.0K) | (292.0K) | 572.0K | 433.0K | 287.0K |
| Other Non-Op Income/Expense | (1.1M) | (810.0K) | 183.0K | (215.0K) | 281.0K |
| Non-Operating Income (excl Interest) | (44.0K) | 220.0K | (183.0K) | 215.0K | (281.0K) |
| EBT (Pre-Tax Income) | (15.0M) | (14.0M) | (12.0M) | (19.0M) | (22.6M) |
| Income Tax Expense | (270.0K) | 3.0K | (93.0K) | (186.0K) | (431.0K) |
| Bottom Line | |||||
| Net Income | (14.8M) | (14.0M) | (11.9M) | (18.8M) | (22.2M) |
| Earnings from Cont. Ops | (14.8M) | (14.0M) | (11.9M) | (18.8M) | (22.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (14.8M) | (14.0M) | (11.9M) | (18.8M) | (22.2M) |
| Per Share | |||||
| Basic EPS | ($1.70) | ($1.65) | ($1.59) | ($3.42) | ($4.69) |
| Diluted EPS | ($1.70) | ($1.65) | ($1.59) | ($3.42) | ($4.69) |
| Revenue Per Share | $3.93 | $3.78 | $3.37 | $2.91 | $1.82 |
| Shares | |||||
| Basic Shares Outstanding | 9.4M | 8.5M | 7.5M | 5.5M | 4.7M |
| Diluted Shares Outstanding | 9.4M | 8.5M | 7.5M | 5.5M | 4.7M |
| Profitability Metrics | |||||
| EBITDA | (12.5M) | (11.7M) | (10.7M) | (17.8M) | (22.0M) |
| D&A | 1.4M | 1.7M | 1.3M | 1.3M | 596.0K |
| EBIT | (13.9M) | (13.4M) | (12.0M) | (19.0M) | (22.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026